🔎 Trials Near Me

Pradžia › Išsėtinė sklerozė › Ilinoisas

Išsėtinė sklerozė klinikiniai tyrimai Ilinoisas

19 tyrimai dėl Išsėtinė sklerozė ieško dalyvių vietose Ilinoisas.

Miestai Ilinoisas

Oficialus tyrimo tekstas (anglų kalba)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Evanston
  • ir dar 1
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Consultants in Neurology- Site Number : 8400020, Northbrook
Renkami dalyviai3 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • University of Chicago Medical Center, Chicago
Renkami dalyviai3 fazė
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-09-10 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

  • Shirley Ryan AbilityLab, Chicago
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-28 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-20 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

  • University of Illinois at Chicago, Chicago
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Renkami dalyviai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Renkami dalyviai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-06-04 · NCT05051618

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

  • Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-11 · NCT07167680

Nomad P-KAFO Study

  • Shirley Ryan AbilityLab, Chicago
Renkami dalyviai
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2026-05-11 · NCT05644522

Intermittent Hypoxia in Persons With Multiple Sclerosis

  • Shirley Ryan AbilityLab, Chicago
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-20 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-03-17 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-03-17 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

  • Shirley Ryan AbilityLab, Chicago
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-02-23 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Renkami dalyviai
Amžius nuo 40 iki 90 · Visoms lytims · Atnaujinta 2026-01-21 · NCT07355387

An Individualized-health eLibrary App for People With Multiple Sclerosis

  • University of Illinois Urbana-Champaign, Champaign
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-08-24 · NCT05124600

Remote Evaluation of MIND Diet

  • University of Illinois Urbana-Champaign, Urbana
Renkami dalyviai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2024-06-27 · NCT06450977

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.